To Top

Feb. 28, 2014

TOPIC: Featured News, Industry, Patients & Members

FDA Creates New Web-Based Educational Tool About the Agency

Posted by Mary Dunkle

The Food and Drug Administration’s Office of Orphan Products Development (OOPD), in collaboration with the FDA Center for Drug Evaluation and Research (CDER), has launched a web-based educational tool for rare disease patients, advocacy groups, researchers and industry on various FDA-related topics.

Several topics are addressed, including the essentials of interacting with FDA and expanded access to products under development. FDA plans to develop additional topics in the future.

Above is the video  introduction for the program by NORD President and CEO Peter L. Saltonstall.  Visit FDA’s educational resource here.

One Response to “FDA Creates New Web-Based Educational Tool About the Agency”

  1. Donna Corley says:

    I would like to see research on the rare spine disease Tarlov Cyst Disease and also on Arachnoiditis spine disease. I have both and have had a really hard time getting any neuro to see me in my area because most doctors doesn’t know what Tarlov Cyst or Arachnoiditis even is!!